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Copyright © 2011 JCBN 2011 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. We measured the energy expenditure weekly in patients under 
going a pylorus preserving pancreatoduodenectomy for bile duct
cancer or pancreatic tumors. Twelve patients (5 women and 7 men;
mean age 70.1 years) were enrolled in this study, and their resting
energy expenditure levels were determined by indirect calorimetry.
In these patients, a significant correlation was observed between
the measured resting energy expenditures and the predicted
resting energy expenditures calculated by the Harris Benedict equa 
tion. The resting energy expenditures measured before surgery
were almost the same as the predicted resting energy expendi 
tures (measured resting energy expenditure: 22.4 ± 3.9 kcal/kg/
day vs predicted resting energy expenditure: 21.7 ± 2.0 kcal/kg/
day). The measured resting energy expenditure/predicted resting
energy expenditure ratio, which reflects the stress factor, was
1.02 ± 0.10. After the pylorus preserving pancreatoduodenectomy,
a significant increase in energy expenditure was observed, and
the measured resting energy expenditure was 25.7 ± 3.5 kcal/kg/day
on postoperative day 7 and 25.4 ± 4.9 kcal/kg/day on postoperative
day 14. The measured resting energy expenditure/predicted resting
energy expenditure ratio was 1.16 ± 0.14 on postoperative day 7,
and 1.16 ± 0.18 on postoperative day 14 respectively. In conclusion,
patients undergoing a pylorus preserving pancreatoduodenectomy
showed a hyper metabolic status as evaluated by their measured
resting energy expenditure/predicted resting energy expenditure
ratio. From our observations, we recommend that nutritional
management based on 30 kcal/body weight/day (calculated by
the measured resting energy expenditure×activity factor 1.2–1.3)
may be optimal for patients undergoing a pylorus preserving
pancreatoduodenectomy.
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Introduction It has been widely recognized that marked metabolic changes
occur after a major operation.(1,2) Therefore, the energy
expenditure must be markedly changed during the perioperative
period.(3) Nutritional support is essential for patients undergoing
major surgery, and nutritional therapies such as total parenteral
nutrition or enteral nutrition are integral to the management of
these patients. However, surgery causes a state of insulin resis-
tance, and changes in glucose metabolism occur after surgery,
and overfeeding with high loads of carbohydrates has been
associated with clinical complications.(4,5) Therefore, knowledge
of the optimal energy requirements is very important in the nutri-
tional management of the patients undergoing surgery.
An evaluation of the energy requirements of patients under-
going surgery is critical in planning optimal nutritional therapy.
Typically, the total energy of the parenteral or enteral nutrition is
determined by using the predicted resting expenditure (pREE)
calculated by the Harris-Benedict equation,(4) and the total energy
requirement is calculated by the pREE × activity factor × stress
factor.(5) On the other hand, the mREE can be determined by
indirect calorimetry.
There have been several studies reporting that the energy
expenditure of patients undergoing surgery changes to a hyper-
metabolic status.(1–3,6) However, there have not been any reports on
the energy metabolism of patients undergoing a pancreatoduode-
nectomy. Currently, the pylorus-preserving pancreatoduodenec-
tomy (PPPD) is generally accepted as the preferred procedure for
pancreatic head cancer or bile duct tumors.(7–11) In this study, we
evaluated the change in the energy metabolism of patients under-
going PPPD, and determined the optimal energy requirements for
their nutritional management.
Subjects and Methods
Patients. Twelve patients with bile duct cancer or pancreatic
tumors (5 women and 7 men, median age 70.1 years old) were
enrolled in this study. The patients were admitted to the Gastro-
intestinal Surgery Unit of Shiga University of Medical Science
Hospital. The ethics committee of the Shiga University of Medical
Science approved this study.
Four patients had pancreatic cancers, 6 patients had bile duct
carcinomas, and 2 patients had intraductal papillary mucinous
neoplasms (IPMN). All patients underwent PPPD without major
complications. Parenteral nutrition was started before surgery in
three patients, and parenteral nutrition and enteral nutrition were
started on postoperative day (POD) 1 in other patients. Oral diets
were started on POD 8. The total energy of the parenteral nutrition
(TPN), enteral nutrition (EN) and oral diet was 33.2 ± 7.6 kcal/kg/
day before surgery, 29.5 ± 7.8 kcal/kg/day on POD 7 and 24.3 ±
8.4 kcal/kg/day on POD 14. Fat emulsions were not used for TPN
during this period.
Indirect calorimetry. We performed weekly indirect calo-
rimetry on patients undergoing PPPD. The mREEs and non pro-
tein respiratory quotients (npRQ) were measured by computed




Science Co., Osaka, Japan).(12,13) Indirect calorimetry (IC) was
performed in the hospital room on the morning after a 10-h
overnight fast before surgery. However, the infusion of parenteral
nutrition was maintained on POD 7 and POD 14. The period flow
and gas calibration were performed prior to all measurements.
After resting for a minimum of 30 min, the patients were assessed
in the supine position with a facemask. A pump drew ambient air
through a facemask at a constant rate. After equilibrium was
reached for 10 min, the respiratory exchange was performed
continuously over 30 min. The mREE and npRQ data were
obtained every minute.
The mREE was calculated from the oxygen consumption (VO2)
and carbon dioxide production (VCO2) by the Weir equation.(14):
mREE = (3.94 × VO2 +1 . 1 1× VCO2) × 1.44
Measurement of the non protein RQ was calculated as
R Q=V C O 2/VO2. The measured mREE was then compared with
the pREE (predicted resting energy expenditure) calculated by the
Harris and Benedict equation.(15):
Men: pREE = 66.47 + 13.75 × W [weight (kg)] + 5.0
× H [height (cm)] – 6.75 × A [age (year)].
Women: pREE = 665.09 + 9.56 × W [weight (kg)] + 1.84
× H [height (cm)] – 4.67 × A [age (year)].
Statistical analyses. Statistical analyses were performed
using Student’s paired t tests when appropriate. The correlations
were investigated with Spearman rank correlation tests. The
results are presented as mean ± SD, and a p value <0.05 was
considered to be statistically significant.
Results
The characteristics of the patients are shown on Table 1. The
BMI of these patients was 21.4 ± 3.8 kg/m2, and the average
total protein, serum albumin, total cholesterol, prealbumin and
retinol-binding protein levels were normal. The total lymphocyte
counts were 1571.5 ± 285.9/mm3.
The mREE in these patients determined by indirect calorimetry
before the surgery was 1198.0 ± 191.7 kcal/day. On the other
hand, the pREE calculated by the Harris-Benedict equation was
1174.5 ± 175.2 kcal/day. There was a positive correlation between
the pREE and mREE (p<0.05) (Fig. 1).
The mREE/body weight measured before the operation was
almost the same as the pREE/body weight (mREE: 22.4 ± 3.9
kcal/kg/day vs pREE: 21.7 ± 2.0 kcal/kg/day), and the mREE/
pREE ratio, which reflects the stress factor, was 1.02 ± 0.11. There
were no significant differences among mREEs of the patients
with pancreas cancer, bile duct carcinoma and IPMN. The mREE/
body weight of these patients was almost the same as that of the
controls reported previously.(12,13)
The npRQ of these patients measured by indirect calorimetry
before surgery was 0.87 ± 0.06, and was almost the same as that of
the controls reported previously.(12,13) There was no significant
correlation between the npRQ and mREE.
As shown in Fig. 2, a significant increase in energy expenditure
Table 1. Background
No of patients 12
pancreas head cancer 4
bile duct cancer 6
IPMN 2
Female/Male 5/7
Age (yrs) 70.1 ± 7.1
Height (cm) 159.6 ± 7.0
Body weight (kg) 54.8 ± 11.3
BMI (kg/m2) 21.4 ± 3.8
Laboratory data
Total Protein (g/dl) 6.2 ± 0.6
Albumin (g/dl) 3.5 ± 0.4
Total Lymphocyte cell counts (/mm3) 1571.5 ± 285.9
Total Cholesterol (mg/dl) 169.3 ± 32.8
C reactive protein (mg/dl) 1.3 ± 2.1
Prealbumin (mg/dl) 20.1 ± 7.2
Retinol binding protein (mg/dl) 2.6 ± 1.3
Energy expenditure
measured resting energy expenditure (kcal/day) 1198.0 ± 191.7
predicted resting energy expenditure (kcal/day) 1174.5 ± 175.2
Fig. 1. Correlation between the measured resting energy expenditure
(mREE) and the predicted resting energy expenditure (pREE). The mREE
was measured by indirect calorimetry, and the pREE was calculated by
the Harris Benedict equation. There was a positive correlation between
the mREE and pREE in patients with bile duct carcinoma or pancreatic
head tumors. J. Clin. Biochem. Nutr. | May 2011 | vol. 48 | no. 3 | 185
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was observed after PPPD. The mREE of the patients undergoing a
PPPD was 25.7 ± 3.5 kcal/kg/day on POD 7 and 25.4 ± 4.9 kcal/
kg/day on POD 14. The mREE/pREE ratio was 1.16 ± 0.14 on
POD 7, and 1.16 ± 0.18 on POD 14 respectively. However, the
npRQ did not change significantly during the perioperative period
(Fig. 3).
Discussion
This is the first report on the resting energy expenditure in
patients undergoing a PPPD. In this study, we showed that the
mREE measured by IC in patients with bile duct carcinomas or
pancreatic tumors was not elevated before surgery. Their mREE
was the same as the pREE calculated by Harris-Benedict equation,
and was the same as the mREE of healthy controls. Previous
studies have suggested that the mREE may be elevated in patients
with specific types of tumors. It has been reported that patients
with lung cancers or sarcomas have increased energy expenditure.
Falconer et al.(15) also reported that the REE was significantly
elevated in pancreatic cancer patients who were losing weight.
This elevated REE was reported to be associated with some
proinflammatory cytokines such as IL-6 or TNF-α. A progressive
increase in tumor size is associated with an increase in oxygen
consumption.(16) In our study, however, the patients with bile duct
cancer or pancreatic tumors enrolled in this study had an operative
indication for PPPD, and hence cachexic patients were not
included in this study. The BMIs and other nutritional parameters
of these patients were within the normal range, and had a good
nutritional condition. This must be the reason why the preopera-
tive REE in these patients was not elevated in this study.
The resting energy expenditure (pREE), calculated by the
Harris-Benedict equation,(17) has been widely used to evaluate
the energy status of patients. The total energy requirement is
calculated by pREE × activity factor × stress factor.(18) Theoreti-
cally, the pREE is expected to be equal to the mREE in healthy
humans, and the mREE/pREE ratio is a marker for a hyper-
metabolic status.(12,19) In this study, the mREE was increased after
PPPD, and was significantly higher than the pREE, and was also
higher than the preoperative mREE (p<0.05). The mREE/pREE,
which reflects the stress factor, was elevated to 1.16 on POD 7 and
POD 14. From these results, it is apparent that the stress factor
for bile duct cancer or pancreatic tumors surgery should be 1.2 in
patients without major complications.
Surgical trauma is generally considered to produce an increase
in energy metabolism, and surgical stress, as well as burns or
sepsis, causes an increase in the mREE. Systemic inflammatory
response syndrome (SIRS) describes a clinical response arising
from a non-specific origin. SIRS may be initiated by a major
operation, as well as by infection. The elevated mREE after
surgery was associated with operative SIRS, and the mREE was
further increased in patients with infectious complications.(2)
The increased rates of mREE in patients undergoing abdominal
surgery are controversial. Previously, it has been reported that
the REE was significantly increased after abdominal surgery,
and TPN therapy consisting 45 kcal/kg day was optimal for these
patients. This means that measurement of energy requirement
can be calculated by the pREE × 1.75. Rutten et al. also reported
that pREE × 1.75–2.0 kcal/day should be optimal for TPN in the
patients undergoing major surgery. However, Federix et al.(3)
showed a 10% increase in the mREE in patients undergoing
Fig. 2. Changes in the measured resting energy expenditure (mREE), and the mREE/the predicted resting energy expenditure REE (pREE) ratio. The
pREE was calculated by Harris Benedict equation. Significant increases were observed in the mREE and mREE/pREE ratio on POD 7 or POD 14 after
the PPPD.
Fig. 3. Changes in the respiratory quotient in patients undergoing
PPPD. No significant changes were observed in the npRQ after surgery.doi: 10.3164/jcbn.10 83
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gastrointestinal surgery without major complication. Shaw et al.(20)
also reported that the infusion of 110% of REE may be suitable for
TPN in patients with gastrointestinal surgery.
Our results showed that the mREE was almost 25.5 kcal/kg/day
just after PPPD surgery, and the mREE/pREE ratio was 1.16 on
POD 7 and POD 14. The measurement of energy requirement is
very critical for nutritional management in patients undergoing
major surgery such as pancreatic cancer or esophageal cancer,
because over feeding has been associated with some clinical
complications.(4) From our findings, the stress factor of patients
undergoing PPPD should be set at 1.2 in patients without major
complications. This factor was compatible to that of patients
undergoing esophageal cancer surgery reported by Sato et al.(21)
Although one would be more likely to find stress-induced hyper-
metabolism on the earlier postoperative days, the increase in the
mREE of patients undergoing an esophagectomy was almost the
same as during the first seven days.(21) Recently, perioperative
management has been dramatically improved. In particular, infec-
tion control has been advanced, and may prevent infection induced
SIRS in the patients undergoing major surgery.
In this study, a significant change in the npRQ after PPPD
was not observed. In previous reports, the npRQ was reduced in
patients after a liver resection.(22) This fact means that the energy
substrate of the remnant liver is principally fatty acids rather
than glucose after a liver resection. In patients undergoing PPPD,
however, glucose is mainly utilized after the surgery as well as in
patients undergoing an esophagectomy.(23,24)
In conclusion, patients undergoing PPPD have a hyper-metabolic
status just after surgery, and the mREE/pREE ratio was signifi-
cantly increased to 1.16. From our results, the daily energy
requirements for patients undergoing PPPD are recommended at
30 kcal/body weight (mREE 25.7 kcal ± 3.5 kcal/kg/day × active
factor 1.2–1.3).
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